Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,966,358 | 2,700,056 | 1,497,202 | 4,721,563 | 3,551,456 |
| Depreciation Amortization | 289,850 | 194,290 | 100,511 | 612,461 | N/A |
| Accounts receivable | N/A | N/A | N/A | -380,492 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 152,981 | N/A |
| Other Working Capital | -284,930 | -450,676 | -434,182 | 193,634 | -411,536 |
| Other Operating Activity | 228,571 | -60,614 | -541,061 | 350,538 | 1,201,678 |
| Operating Cash Flow | $4,199,849 | $2,383,056 | $622,470 | $5,650,684 | $4,341,598 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 224,545 | 223,189 | 46,238 | 397,966 | 396,050 |
| PPE Investments | -451,475 | -264,092 | -115,822 | -710,704 | -441,618 |
| Net Acquisitions | 343,377 | 341,305 | 349,135 | N/A | N/A |
| Purchase Of Investment | -301,331 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 4,771 | 4,150 | 4,245 | 6,241 | N/A |
| Purchase Sale Intangibles | -29,075 | -23,119 | -4,548 | -61,514 | -41,118 |
| Other Investing Activity | -29,075 | -23,119 | -4,548 | -61,514 | -41,118 |
| Investing Cash Flow | $-209,187 | $281,432 | $279,247 | $-368,011 | $-86,686 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -1,900,876 | -1,149,884 | -575,928 | -2,615,126 | -1,921,510 |
| Dividend Paid | -1,924,135 | -1,912,521 | -1,956,398 | -2,115,708 | -2,112,148 |
| Other Financing Activity | 0 | 0 | 354,743 | 0 | 0 |
| Financing Cash Flow | $-3,825,011 | $-3,062,405 | $-2,177,583 | $-4,730,834 | $-4,033,658 |
| Exchange Rate Effect | 9,990 | 16,154 | 19,708 | 12,124 | 11,392 |
| Beginning Cash Position | 2,039,092 | 2,026,783 | 2,073,281 | 1,874,468 | 1,871,314 |
| End Cash Position | 2,214,731 | 1,645,020 | 817,124 | 2,438,431 | 2,103,960 |
| Net Cash Flow | $175,640 | $-381,763 | $-1,256,158 | $563,963 | $232,646 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,199,849 | 2,383,056 | 622,470 | 5,650,684 | 4,341,598 |
| Capital Expenditure | -452,369 | -264,982 | -116,277 | -711,417 | -441,974 |
| Free Cash Flow | 3,747,480 | 2,118,074 | 506,192 | 4,939,267 | 3,899,624 |